Background The number of older adults has been constantly growing around the globe.
Consequently, multimorbidity and related polypharmacy have become an increasing …

A high rate of polypharmacy is, in part, a consequence of the increasing proportion of
multimorbidity in the ageing population worldwide. Our understanding of the potential harm …

Introduction: Polypharmacy, the use of multiple medications by one individual, is
increasingly common among older adults. Caring for the growing number of older people …

Objective Polypharmacy is widespread among older people, but the adverse outcomes
associated with it are unclear. We aim to synthesize current evidence on the adverse health …

3D printing (3DP) is forecast to be a highly revolutionary technology within the
pharmaceutical sector. In particular, the main benefits of 3DP lie in the production of small …

Polypharmacy is a growing and major public health issue, particularly in the geriatric
population. This study aimed to examine the association between polypharmacy and the risk …

Aims Frailty is a complex geriatric syndrome resulting in decreased physiological reserves.
Frailty and polypharmacy are common in older adults and the focus of extensive studies …

The microbiota-gut-brain axis is a bidirectional communication system that is poorly
understood. Alzheimer's disease (AD), the most common cause of dementia, has long been …

Chronic pain is highly prevalent among older adults where it is associated with significant
suffering, disability, social isolation, and greater costs and burden to health care systems …

Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in a rapid
change in workload across healthcare systems. Factors related to this adaptation in UK …